BLACKMORES chairman Stephen Chapman has announced the appointment of company chief operating officer Richard Henfrey (pictured) as the new ceo for the firm effective yesterday (PD breaking news).
The appointment follows the recent resignation of Christine Holgate (PD 28 Jun 17).
Both internal and external applications were accepted in the extensive process, the company ASX announcement said.
"Richard has been at the forefront of Blackmores' strategy development for more than eight years and has driven key business projects that positioned us well for the transformation of our business over that time," said Chapman.
"He has demonstrated his integrity, leadership capability and strong strategic and financial acumen throughout this time and has earned the respect of his team, our business partners and the Board," he said, adding: "He met all of our criteria to become the next leader of the Blackmores business".
In addition to his coo role, Henfrey has also held executive team roles across Strategic Sourcing and People and Strategy.
He was also president of the complementary medicines industry association, Complementary Medicines Australia.
Prior to Blackmores, Henfrey had worked for Telstra as director of Technical Sales, Telstra Business, gm, Business Sales NSW and gm of Marketing Strategy, Telstra Business and Government.
Henfrey emigrated to Australia in 2003 with his wife and children after fulfilling a director of strategy role with Energis plc, playing a key role in financially restructuring the business.
His qualifications include a honours degree in Natural Science from Cambridge University specialising in genetics as well as molecular and cell biology.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 17
